Shanghai Fosun Pharmaceutical (02196) spent 19.997 million yuan on April 9 to repurchase 848,400 shares of A shares.

date
09/04/2025
avatar
GMT Eight
Shanghai Fosun Pharmaceutical (02196) announced that on April 9, 2025, the company spent 1999.7 million yuan to repurchase 848,400 A shares.
pre
Sino Biopharm (01177) spent 13.372 million Hong Kong dollars on April 9th to repurchase 4 million shares.
HENLIUS (02696): The Phase 1b/2 clinical study of HLX43 in combination with Hansey (Siltuximab Injection) for the treatment of patients with advanced/metastatic solid tumors has completed the first patient dosing in China.
next

RECOMMEND

recommend

Shenzhen Tongyi Industry (300538.SZ) controlling shareholder and one senior executive collectively reduced their shareholding by 2.52%.

date
20/04/2025
recommend

The two shareholders of Guangdong Tianhe Agricultural Means Of Production (002999.SZ) are planning to reduce their holdings by a total of not more than 1.2973 million shares.

date
20/04/2025
recommend

Significantly lower the target price for US stocks, Wall Street "torn reports", but still insist "will rise this year"

date
20/04/2025

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: [email protected]